MONARCS
Results Treated patients had a 36% mortality; untreated patients, 33%
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
MONARCS
Immunology A clinical trial–Monoclonal Anti-TNF: a Randomized Controlled Sepsis trial which evaluated the efficacy of afelimomab in managing sepsis and septic shock, selecting the Pts using Il-6, a cytokine marker for severity of inflammation; treated Pts had a 36% mortality; untreated Pts, 33%. See Afelimomab, Sepsis.McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.